Zimmer Biomet takes home the Orthopaedic Product Innovation of the Year Award at the 2023 Healthcare Asia Medtech Awards

Recognised for enhancing the precision, efficiency, and personalisation of Total Hip Replacement surgeries.

Zimmer Biomet, a global medical technology leader, has been hailed with the Orthopaedic Product Innovation of the Year at the 2023 Healthcare Asia Medtech Awards for its ROSA HIP® technology and ONE Planner™ Hip web-based surgical software. 

As part of Zimmer Biomet's ROSA Robotics technology platform, ROSA HIP® is a robotically assisted surgical assistant for Total Hip Replacement. During surgery, ROSA supports surgeons with intricate planning of the hip joint, enabling them to align implants more precisely in accordance with the patient's anatomy. This planning and delivery technology is a part of ZBEdge^TM, which combines connected digital and robotic technologies to provide data-driven clinical insights. ONE Planner™ Hip is a web-based preoperative planner designed to enhance surgeons’ efficiency and accuracy by enabling them to create a preoperative plan within three clicks of the computer mouse via the auto-plan mode. With ROSA HIP® and the ONE Planner™ Hip platform, patient-specific acetabular and femoral mapping is possible to improve surgical delivery and outcomes.

Zimmer Biomet has been awarded three times in a row by Healthcare Asia. The company continues to focus investment on new technologies and remains committed to alleviating pain and improving the quality of life for patients around the world. With their innovative use of data, analytics, and artificial intelligence to improve the patient experience, ROSA HIP® t and ONE Planner™ Hip are a testament to Zimmer Biomet’s continuing innovation and transformation from an implant manufacturer to a medical technology company.